Kezar Life Sciences Inc [NASDAQ: KZR] closed the trading session at $0.77.
The stocks have a year to date performance of -18.39 percent and weekly performance of 36.46 percent. The stock has been moved at -15.97 percent over the last six months. The stock has performed 29.30 percent around the most recent 30 days and changed 32.49 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 515.16K shares, KZR reached to a volume of 16148639 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Kezar Life Sciences Inc [KZR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for KZR shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on KZR stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Kezar Life Sciences Inc shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on August 11, 2023. The new note on the price target was released on March 16, 2023, representing the official price target for Kezar Life Sciences Inc stock. Previously, the target price had yet another raise to $19, while Wells Fargo analysts kept a Overweight rating on KZR stock.
The Average True Range (ATR) for Kezar Life Sciences Inc is set at 0.05, with the Price to Sales ratio for KZR stock in the period of the last 12 months amounting to 8.06. The Price to Book ratio for the last quarter was 0.37, with the Price to Cash per share for the same quarter was set at 2.25.
KZR stock trade performance evaluation
Kezar Life Sciences Inc [KZR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 36.46. With this latest performance, KZR shares gained by 29.30% in over the last four-week period, additionally sinking by -15.97% over the last 6 months – not to mention a drop of -34.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KZR stock in for the last two-week period is set at 75.34, with the RSI for the last a single of trading hit 82.47, and the three-weeks RSI is set at 69.36 for Kezar Life Sciences Inc [KZR]. The present Moving Average for the last 50 days of trading for this stock 0.6021, while it was recorded at 0.5893 for the last single week of trading, and 0.7628 for the last 200 days.
Kezar Life Sciences Inc [KZR]: An insightful look at the core fundamentals
Kezar Life Sciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.58 and a Current Ratio set at 9.58.
Kezar Life Sciences Inc [KZR]: Institutional Ownership
There are presently around $54.08%, or 63.47%% of KZR stock, in the hands of institutional investors. The top three institutional holders of KZR stocks are: SUVRETTA CAPITAL MANAGEMENT, LLC with ownership of 7.17 million shares, which is approximately 9.8456%. AVIDITY PARTNERS MANAGEMENT LP, holding 5.03 million shares of the stock with an approximate value of $$3.02 million in KZR stocks shares; and AVIDITY PARTNERS MANAGEMENT LP, currently with $$1.64 million in KZR stock with ownership which is approximately 3.7653%.
